Type 2 diabetes mellitus is a risk factor for the development of hypertension in postmenopausal women

Journal of Hypertension

Volumn 24, Issue 10, 2006, Pages 2017-2022

  Rossi, Rosario ^a,b   Turco, Vincenzo ^a   Origliani, Giorgia ^b   Modena, M Grazia ^a,b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Diabetes mellitus; Hypertension; Menopause; Women

Indexed keywords

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART DEATH; HUMAN; HYPERTENSION; INCIDENCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

EID: 33748541284     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000244951.72664.4b     Document Type: Article

References (36)

1. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-Reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286:327-334.
2. Snow V, Weiss KB, Mottur-Pilson C. The evidence base for tight blood pressure control in the management of type 2 diabetes mellitus. Ann Intern Med 2003; 138:587-592.
3. Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension and cardiovascular disease. An update. Hypertension 2001; 37:1053-1059.
4. The National High Blood Pressure Education Program Working Group. The National High Blood Pressure Education Program Working Group report on hypertension in diabetes. Hypertension 1994; 23:145-158.
5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2497.
6. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR. Heymsfield SB. The metabolic syndrome. Prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003; 163:427-436.
7. Roberts WC. The metabolic syndrome. Am J Cardiol 2004; 93:274.
8. Miranda PJ, DeFronzo RA, Califf RM, Guyton JR. Metabolic syndrome: evaluation of pathological and therapeutic outcomes. Am Heart J 2005; 149:20-32.
9. Morales PA, Mitchell BD, Valdez RA, Hazuda HP, Stern MP, Haffner SM. Incidence of NIDDM and impaired glucose tolerance in hypertensive subjects. The San Antonio Heart Study. Diabetes 1993; 42:154-161.
10. Alderman MH, Cohen H, Madhavan S. Diabetes and cardiovascular events in hypertensive patients. Hypertension 1999; 33:1130-1134.
11. Prisant LM. Preventing type II diabetes mellitus. J Clin Pharmacol 2004; 44:406-413.
12. Okosun IS, Chandra KM, Choi S, Christman J, Dever GE, Prewitt TE. Hypertension and type 2 diabetes comorbidity in adult in the United States: risk of overall and regional adiposity. Obes Res 2001; 9:1-9.
13. Staessen JA, Bieniaszewski L, Brosens I, Fagard R. The epidemiology of menopause and its association with cardiovascular disease. In: Messerli FH, editor. Hypertension in postmenopausal women. New York, New York: Marcel Dekker Inc; 1996, pp. 43-78.
14. Klein BE, Klein R, Moss SE. Blood pressure in a population of diabetic persons diagnosed after 30 years of age. Am J Pub Health 1984; 74:336-339.
15. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risk. U.S. population data. Arch Intern Med 1993; 153:598-615.
16. Harris MI, Flegal KM, Cowie CC, Eberhardt MD, Goldstein DE, Little RR, et al. Prevalence of diabetes, impaired fasting glucose, and impaired fasting glucose tolerance in US adults: the Third National Health and Nutrition Survey, 1988-1994. Diabetes Care 1998; 21:518-524.
17. Report of the Expert Commettee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20:1183-1197.
18. Sowers JR. Obesity and cardiovascular disease. Clin Chem 1998; 44:1821-1825.
19. Khaodiar L, McCowen KC, Blackburn GL. Obesity and its comorbid conditions. Clin Cornerstone 1999; 2:17-31.
20. Weiderpass E, Persson I, Adami HO, Magnusson C, Lindgren A, Baron JA. Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer. Cancer Causes Control 2000; 11:185-192.
21. Giampaoli S, Panico S, Meli P, Conti S, Lo Noce C, Pilotto L, Vanuzzo D. Cardiovascular risk factors in postmenopausal women. Ital Heart J 2000; 1:1180-1187.
22. Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM. C-Reactive protein and the risk of depeloping hypertension. JAMA 2003; 290:2945-2951.
23. Rossi R, Chiurlia E, Nuzzo A, Cioni E, Origliani G, Modena MG. Flow-mediated vasodilation and the risk of developing hypertension in healthy postmenopausal women. J Am Coll Cardiol 2004; 44:1636-1640.
24. Rossi R, Cioni E, Nuzzo A, Origliani G, Modena MG. Endothelial-dependent vasodilation and incidence of type 2 diabetes mellitus in a population of healthy postmenopausal women. Diabetes Care 2005; 28:702-707.
25. Sampaio RC, Tanus-Santos JE, Melo SE, Hyslop S, Franchini KG, Luca IM, Moreno H. Hypertension plus diabetes mimics the cardiomyopathy induced by nitric oxide inhibition in rats. CHEST 2002; 122:1412-1420.
26. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998; 83:847-850.
27. Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ. Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 1996; 45:633-638.
28. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-Reactive protein in healthy subjects: association with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 19:972-978.
29. Hingorani AD, Cross J, Kharbanda RK, Mullen MJ, Bhagat K, Taylor M, et al. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation 2000; 102:994-999.
30. Fichtlscherer S, Rosemberger G, Walter DH, Breuer S, Dimmeler S, Zeiher AM. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 2000; 102:1000-1006.
31. Taddei S, Virdis A, Ghiadoni L, Mattei P, Sudano I, Bernini G, et al. Menopause is associated with endothelial dysfunction in women. Hypertension 1996; 28:576-582.
32. Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 1994; 24:471-476.
33. Majmudar NG, Robson SC, Ford GA. Effects of the menopause, gender, and estrogen replacement therapy on vascular nitric oxide activity. J Clin Endocr Metab 2000; 85:1577-1583.
34. Epstein M, Sowers JR. Diabetes mellitus and hypertension. Hypertension 1992; 19:403-418.
35. Weir MR. Diabetes and hypertension: blood pressure control and consequences. Am J Hypertens 1999; 12:170S-178S.
36. Ross R. Aherosclerosis - an inflammatory disease. N Engl J Med 1999; 340:115-126.